Fusion Pharm Inc
The Evolution of Radiopharmaceuticals - Fusion Pharma - Home
to Targeted Radiopharmaceuticals. Our team is dedicated to improving the lives of cancer patients and positively impacting patients' families and the community.
Acquisition of Fusion completed - AstraZeneca
AstraZeneca today announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company.
AstraZeneca to acquire Fusion to accelerate the development of ...
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation RCs. Fusion connects alpha particle emitting ...
Acquisition of Fusion Pharmaceuticals Completed - PR Newswire
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca. Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology ...
Fusion Pharmaceuticals | LinkedIn
Fusion Pharmaceuticals | 17255 followers on LinkedIn. Based in Hamilton, ON & Boston, MA, Fusion is developing next-generation ...
FusionPharm, Inc. (FSPM) - Yahoo Finance
1y Target Est --. FusionPharm, Inc. Overview Pharmaceutical Retailers / Healthcare.
Fusion Pharmaceuticals Inc - Company Profile and News - Bloomberg
Company profile page for Fusion Pharmaceuticals Inc including stock price, company news, executives, board members, and contact information.
Fusion Pharmaceuticals Inc. - SEC.gov
Fusion Pharmaceuticals Inc. · This company's Exchange Act registration has been revoked · This company's Exchange Act registration as a Municipal Advisor has ...
Fusion Pharmaceuticals Inc - Company Profile - GlobalData
Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for ...
AstraZeneca completes Fusion Pharmaceuticals acquisition
AstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical company Fusion Pharmaceuticals.
Acquisition | FUSION PHARMACEUTICALS INC | 4th June 2024
ASTRAZENECA PLC made a cash offer for FUSION PHARMACEUTICALS INC of USD 21 per FUSION PHARMACEUTICALS INC share held.
Fusion Pharmaceuticals Inc. (Exact name of registrant as specified in its charter). Canada*, 2836, Not Applicable. (State or other jurisdiction of incorporation ...
Why Fusion Pharma Is The Latest Billion Dollar Big Pharma Buy In ...
AstraZeneca's $2.4 billion acquisition of Fusion Pharmaceuticals is the third billion-plus dollar Big Pharma radiopharmaceuticals purchase announced in the ...
AstraZeneca bets on next-generation cancer therapy with $2 bln ...
Fusion's most advanced therapy is called FPI-2265, which is currently in a mid-stage trial to treat patients with metastatic castration- ...
Fusion Pharma Limited - Bespoke consultancy services within the pharmaceutical industry - Regulatory Affairs - Quality Assurance - Pharmacovigilance and ...
Fusion Pharmaceuticals (@FusionPharmaInc) / X
Fusion Pharma Announces First Patient Dosing in a Phase 1 Clinical Trial of [225Ac]-FPI-1434... BOSTON, Massachusetts and HAMILTON, Ontario—February 19, 2019- ...
FSPM | Fusion Pharm Inc. Stock Overview (U.S.: OTC) - Barron's
Complete Fusion Pharm Inc. stock information by Barron's. View real-time FSPM stock price and news, along with industry-best analysis.
Fusion Pharmaceuticals - Crunchbase Company Profile & Funding
Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company. It is a spinout of the Centre for Probe Development and Commercialization (CPDC), a ...
FSPM - Fusion Pharm, Inc. | Company Profile - OTC Markets
FusionPharm, Inc's primary focus is to utilize the company's (patent pending) proprietary PharmPod line of cultivation containers for vertical urban farming.
Fusion Pharmaceuticals Company Profile 2024 - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Fusion Pharmaceuticals. Use the PitchBook Platform to explore the full ...